Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 1, 2008, Pages 49-54

  Nakai, Shigeru ^a,b   Akiba, Takashi ^a   Kazama, Junichiro ^a   Yokoyama, Keitaro ^a   Fukagawa, Masashi ^a   Tominaga, Yoshihiro ^a   Iseki, Kunitoshi ^a   Tsubakihara, Yoshiharu ^a  

^a Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic dialysis; Hypercalcemia; Hyperparathyroidism; Hyperphosphatemia; Survival

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; SURVIVAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DISEASES, METABOLIC; CALCIUM; DATABASES, FACTUAL; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 38849119667     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00540.x     Document Type: Article

References (24)

1. Akiba T, Nakai S, Shinzato T et al. Why has the gross mortality of dialysis patients increased in Japan? Kidney Int 2000 57 (Suppl. 74 S60 5.
2. Iseki K, Shinzato T, Nagura Y, Akiba T. Factors influencing long-term survival in patients on chronic dialysis. Clin Exp Nephrol 2004 8 : 89 97.
3. Degoulet P, Legrain M, Reach I et al. Mortality risk factors in patients treated by chronic hemodialysis: report of the Diaphane Collaborative Study. Nephron 1982 31 : 103 10.
4. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990 15 : 458 82.
5. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993 44 : 115 19.
6. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999 55 : 648 58.
7. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999 14 : 1956 60.
8. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998 31 : 607 17.
9. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001 12 : 2131 8.
10. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004 15 : 2208 18.
11. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 2005 16 : 1788 93.
12. Goodkin DA, Young EW, Kurokawa K et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004 44 (Suppl. 2) S16 21.
13. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003 14 : 3270 7.
14. Nakai S, Shinzato T, Sanaka T et al. The current state of chronic dialysis treatment in Japan (as of December 31, 2000). J Jpn Soc Dial Ther 2002 35 : 1155 84.
15. Shinzato T, Nakai S, Fujita Y et al. Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. Nephron 1994 67 : 280 90.
16. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000 15 : 1014 21.
17. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000 342 : 1478 83.
18. Tamashiro M, Iseki K, Sunagawa O et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001 38 : 64 9.
19. Matsuoka M, Iseki K, Fujimoto N et al. Significance of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004 8 : 54 8.
20. Kramer HJ, Saranathan A, Luke A et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006 17 : 1453 9.
21. Wong JS, Port FK, Hulbert-Shearon TE et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999 55 : 2515 23.
22. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003 63 : 793 808.
23. Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Therap Apher Dial 2005 9 : 44 7.
24. Fukagawa M, Kitaoka M, Tominaga Y et al. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003 18 (Suppl. 3 31 33.